EDC Articles - Perficient Blogs

Posts Tagged ‘EDC’

  • Topics
  • Industries
  • Partners





Join Us At Oracle Industry Connect 2018

Perficient is sponsoring Oracle Industry Connect April 10-11 in New York City, and we would like our valued clients to be there. Several key representatives from our life sciences practice will be available to discuss any of your ongoing or upcoming initiatives. Mike Grossman, General Manager Dennis Dougherty, Business Development Executive Rudolf Coetzee, Business Development […]

Read more

Top 5 Pharma & Medical Device Blog Posts From December 2017

Now that January is here, I thought it would be neat to look back at what our readers found most interesting last month. Below are the top five blog posts Perficient’s life sciences practice wrote in December – they’re ranked in order of popularity, with number one being the most viewed piece. Shared Investigator Platform (SIP) Struggles […]

Read more

Clinical Study Migrations: Technical Things to Consider

There are a number of essential technical considerations that should be evaluated when migrating clinical studies from one database to another. Is the target database new or does the incoming data need to be “merged” into an existing database? What if the source application has been customized? What obstacles can be expected? Where does regulatory […]

Read more

[Webinar] An Intro To Clinical Study Migrations

Migrating clinical studies from one database to another (such as Oracle Clinical to Oracle Clinical or Oracle Clinical to Oracle InForm or Medidata Rave), is a complex process that requires a thorough understanding of clinical data management, technology, and the regulations that govern clinical trials. Join me and my colleague, Richard Gavan, for an informational webinar […]

Read more

Tomorrow: Live Oracle Data Management Workbench (DMW) Demo

When it comes to clinical trials, the consequences of bad data can be severe. Research and development becomes complicated and lives can be put at risk. The need for clean clinical data is critical for comprehensive reporting and analysis, ultimately enabling safer drugs and devices to be brought to market faster. Join us this Thursday […]

Read more

If You Use Siebel CTMS, Medidata Rave, Or Veeva Vault…

Then we’ve got a special webinar, just for you. On July 21, we will be having a fireside chat with our client, Alliance Foundation Trials (AFT), a research organization that develops and conducts cancer clinical trials. The chat will include a few presentation slides, so that you’re not looking at a blank screen, but much […]

Read more

FDA Draft Guidance: Using EHR Data In Clinical Trials

We’ve talked a lot in this blog about the use of electronic health records (EHRs) in clinical trials. Recently, my colleague wrote about it on our healthcare blog, so, I thought I would share her post with my pharma and CRO friends. While our previous posts focused on the use of EHR for subject recruitment […]

Read more

Trending: Using EHR Data To Determine Site/Study Feasibility

  According to an article in Clinical Leader that featured Bayer Healthcare’s VP Global Strategy & Development Advisor, by evaluating certain criteria against patient populations, electronic health record (EHR) systems can help sponsors determine trial feasibility and shape better study protocols. This can reduce the number of amendments, which can cost anywhere from $300,000 to […]

Read more

Digital Pill To Track Patients With Hypertension

  Last year, I wrote about Proteus, the company behind the FDA-cleared ingestible sensor that helps monitor patients’ adherence to medication. At that time, the company was running clinical trials in the US, whereas in 2012, the company’s platform was already deployed in the UK. 

Read more

Determining Clinical Trial Feasibility With EHRs And EDC

  In an article from Clinical Leader, Chief Editor, Ed Miseta, and Bayer Healthcare’s VP Global Strategy & Development Advisor, Johann Proeve, discuss using electronic health record (EHR) and electronic data capture (EDC) systems to lower the overall costs of running clinical trials. 

Read more

FDA Wants To Hear About Innovative Technology In Clinical Trials

  Over the last decade, the life sciences industry has gone from running clinical trials on paper or, in many cases, in Excel, to leveraging comprehensive web-based systems, such as electronic data capture (EDC) and clinical trial management systems (CTMS). But, in more recent years, the widespread use of mobile technology has enabled even more […]

Read more

How To Disable Oracle Clinical/RDC User Accounts

  One question we often get relates to disabling Oracle Clinical (OC) and Remote Data Capture (RDC) accounts. What happens to the OC/RDC accounts of users who separate from a company or roll off of a clinical trial? The answer is relatively simple, though not necessarily obvious, because the only way to tell if an […]

Read more

Perficient’s Top 5 Life Sciences Blog Posts From January 2015

Now that February is here, I thought it would be neat to look back at what our readers found most interesting last month. Below are the top five blog posts Perficient’s life sciences practice wrote in January – they’re ranked in order of popularity, with number one being the most viewed piece. 6 Trends In Life Sciences […]

Read more

Eat It Up! No More Self-Reporting For Clinical Trial Subjects

  Let’s face it, relying on clinical trial participants to self-report their medication intake isn’t ideal. Lots of things can go wrong. Patients can administer medication improperly, avoid taking the medication altogether, or even claim they’ve taken the medication when, in actuality, they haven’t. While there are other means of checking whether patients are taking […]

Read more

What The NFL And Pharma Have In Common

There’s been a lot of hoopla around the NFL and their new partnership with Microsoft surrounding the Surface tablet, now deemed the official tablet of the NFL and, of course, Seattle Seahawks QB Russell Wilson’s favorite toy. The deal, in part, outfits NFL teams with tablets to improve communication on the field, photo viewing, and […]

Read more

Why Bother With Computer Systems Validation?

It’s no secret that validation can be a bear. All of that documentation and testing, the multiple phases with pesky transition gates, a million reviews and approvals…it can really slow down an IT project, which often leads to questions about why on Earth we bother with it. Well, it all traces back to rules and regulations […]

Read more

It’s Time To Send Your IT Hassles To Someone Else [VIDEO]

The other day, I was watching Cory Johnson interview Bryson Koehler, CTO and CIO of The Weather Company, on Bloomberg West. While the talk focused on The Weather Company’s business model, I thought several points during the discussion were quite relevant to life sciences companies. Frankly, they’re applicable to most industries. The Weather Channel, which […]

Read more

Navigating The Road To Creating Custom Roles in OC/RDC

On November 13, 2014, I’ll be delivering Taking Ownership of Custom Database Roles in Oracle Clinical and RDC, a one-hour webinar that’ll cover the following topics: Reasons to create custom roles Process of creating a custom role Granting the necessary access and privileges to a new role Granting the new role to the appropriate user […]

Read more

Oops! I Just Deleted Production Data For An EDC Study

Imagine accidently deleting lots of production clinical data. What do you do? How do you recover? Those are the tough questions our client was recently faced with when one of their Oracle Clinical (OC) power users ran the Delete Study Information function in the system with the intention of deleting patient data for only a handful […]

Read more

How One Medical Device Company Is Trying To Increase The Adoption Of Minimally Invasive Surgeries

The benefits of minimally invasive surgeries (MIS) are clear: fewer complications, shorter lengths of hospital stays, fewer readmissions, and lower total costs. However, the adoption rate for MIS is surprisingly low. A large medical device client of ours discovered that fewer than 30% of the tens of millions of potential procedures (of interest to them) […]

Read more

Subscribe to the Weekly Blog Digest:

Sign Up